Dr. Bengt Gustavsson has held several leading positions in life science, both in large organizations such as Novartis and Sanofi-Aventis, and in smaller companies, e.g. Oncopeptides AB, and is now a consultant in medical affairs and clinical research. Bengt Gustavsson has been a non-executive board director in Nanexa AB and WntResearch AB. He holds a M.Sc. in pharmaceutical sciences and a Ph.D. in medical sciences, both from Uppsala University.